FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2021000498> ?p ?o ?g. }

• W2021000498 endingPage "4065" @default.
• W2021000498 startingPage "4056" @default.
• W2021000498 abstract "The mechanisms underlying Tau-related synaptic and cognitive deficits and the interrelationships between Tau species, their clearance pathways, and synaptic impairments remain poorly understood. To gain insight into these mechanisms, we examined these interrelationships in aged non-mutant genomic human Tau mice, with established Tau pathology and neuron loss. We also examined how these interrelationships changed with an intervention by feeding mice either a control diet or one containing the brain permeable beta-amyloid and Tau aggregate binding molecule curcumin. Transgene-dependent elevations in soluble and insoluble phospho-Tau monomer and soluble Tau dimers accompanied deficits in behavior, hippocampal excitatory synaptic markers, and molecular chaperones (heat shock proteins (HSPs)) involved in Tau degradation and microtubule stability. In human Tau mice but not control mice, HSP70, HSP70/HSP72, and HSP90 were reduced in membrane-enriched fractions but not in cytosolic fractions. The synaptic proteins PSD95 and NR2B were reduced in dendritic fields and redistributed into perikarya, corresponding to changes observed by immunoblot. Curcumin selectively suppressed levels of soluble Tau dimers, but not of insoluble and monomeric phospho-Tau, while correcting behavioral, synaptic, and HSP deficits. Treatment increased PSD95 co-immunoprecipitating with NR2B and, independent of transgene, increased HSPs implicated in Tau clearance. It elevated HSP90 and HSC70 without increasing HSP mRNAs; that is, without induction of the heat shock response. Instead curcumin differentially impacted HSP90 client kinases, reducing Fyn without reducing Akt. In summary, curcumin reduced soluble Tau and elevated HSPs involved in Tau clearance, showing that even after tangles have formed, Tau-dependent behavioral and synaptic deficits can be corrected.Background: Various types of Tau aggregates in AD brains may differentially impact neurodegeneration.Results: Curcumin selectively suppresses soluble Tau dimers and corrects molecular chaperone, synaptic, and behavioral deficits.Conclusion: A drug increasing HSPs involved in Tau clearance reduced Tau dimers and improved cognition.Significance: Curcumin that reduced Tau dimers and increased molecular chaperones was efficacious without altering insoluble Tau. The mechanisms underlying Tau-related synaptic and cognitive deficits and the interrelationships between Tau species, their clearance pathways, and synaptic impairments remain poorly understood. To gain insight into these mechanisms, we examined these interrelationships in aged non-mutant genomic human Tau mice, with established Tau pathology and neuron loss. We also examined how these interrelationships changed with an intervention by feeding mice either a control diet or one containing the brain permeable beta-amyloid and Tau aggregate binding molecule curcumin. Transgene-dependent elevations in soluble and insoluble phospho-Tau monomer and soluble Tau dimers accompanied deficits in behavior, hippocampal excitatory synaptic markers, and molecular chaperones (heat shock proteins (HSPs)) involved in Tau degradation and microtubule stability. In human Tau mice but not control mice, HSP70, HSP70/HSP72, and HSP90 were reduced in membrane-enriched fractions but not in cytosolic fractions. The synaptic proteins PSD95 and NR2B were reduced in dendritic fields and redistributed into perikarya, corresponding to changes observed by immunoblot. Curcumin selectively suppressed levels of soluble Tau dimers, but not of insoluble and monomeric phospho-Tau, while correcting behavioral, synaptic, and HSP deficits. Treatment increased PSD95 co-immunoprecipitating with NR2B and, independent of transgene, increased HSPs implicated in Tau clearance. It elevated HSP90 and HSC70 without increasing HSP mRNAs; that is, without induction of the heat shock response. Instead curcumin differentially impacted HSP90 client kinases, reducing Fyn without reducing Akt. In summary, curcumin reduced soluble Tau and elevated HSPs involved in Tau clearance, showing that even after tangles have formed, Tau-dependent behavioral and synaptic deficits can be corrected. Background: Various types of Tau aggregates in AD brains may differentially impact neurodegeneration. Results: Curcumin selectively suppresses soluble Tau dimers and corrects molecular chaperone, synaptic, and behavioral deficits. Conclusion: A drug increasing HSPs involved in Tau clearance reduced Tau dimers and improved cognition. Significance: Curcumin that reduced Tau dimers and increased molecular chaperones was efficacious without altering insoluble Tau." @default.
• W2021000498 created "2016-06-24" @default.
• W2021000498 creator A5010413277 @default.
• W2021000498 creator A5015934449 @default.
• W2021000498 creator A5026702889 @default.
• W2021000498 creator A5032754420 @default.
• W2021000498 creator A5033687468 @default.
• W2021000498 creator A5060496206 @default.
• W2021000498 creator A5067013860 @default.
• W2021000498 creator A5071522178 @default.
• W2021000498 creator A5072208919 @default.
• W2021000498 creator A5073120426 @default.
• W2021000498 creator A5073179224 @default.
• W2021000498 creator A5077689249 @default.
• W2021000498 creator A5080782448 @default.
• W2021000498 date "2013-02-01" @default.
• W2021000498 modified "2023-10-17" @default.
• W2021000498 title "Curcumin Suppresses Soluble Tau Dimers and Corrects Molecular Chaperone, Synaptic, and Behavioral Deficits in Aged Human Tau Transgenic Mice" @default.
• W2021000498 cites W1601066682 @default.
• W2021000498 cites W1893669995 @default.
• W2021000498 cites W1965497520 @default.
• W2021000498 cites W1968553823 @default.
• W2021000498 cites W1976138207 @default.
• W2021000498 cites W1982487434 @default.
• W2021000498 cites W1986782185 @default.
• W2021000498 cites W1987927755 @default.
• W2021000498 cites W1988392976 @default.
• W2021000498 cites W1998440070 @default.
• W2021000498 cites W2001990572 @default.
• W2021000498 cites W2002823741 @default.
• W2021000498 cites W2003061822 @default.
• W2021000498 cites W2003956785 @default.
• W2021000498 cites W2006072142 @default.
• W2021000498 cites W2016758992 @default.
• W2021000498 cites W2018365681 @default.
• W2021000498 cites W2019197358 @default.
• W2021000498 cites W2021608135 @default.
• W2021000498 cites W2022318321 @default.
• W2021000498 cites W2022532556 @default.
• W2021000498 cites W2023035838 @default.
• W2021000498 cites W2032208441 @default.
• W2021000498 cites W2033489717 @default.
• W2021000498 cites W2034002691 @default.
• W2021000498 cites W2035216963 @default.
• W2021000498 cites W2040350223 @default.
• W2021000498 cites W2048865592 @default.
• W2021000498 cites W2053116497 @default.
• W2021000498 cites W2053535174 @default.
• W2021000498 cites W2056666417 @default.
• W2021000498 cites W2061538653 @default.
• W2021000498 cites W2062416537 @default.
• W2021000498 cites W2067574216 @default.
• W2021000498 cites W2073688317 @default.
• W2021000498 cites W2075401349 @default.
• W2021000498 cites W2075823713 @default.
• W2021000498 cites W2076032638 @default.
• W2021000498 cites W2078696245 @default.
• W2021000498 cites W2081445697 @default.
• W2021000498 cites W2084400475 @default.
• W2021000498 cites W2089789496 @default.
• W2021000498 cites W2092704615 @default.
• W2021000498 cites W2093852116 @default.
• W2021000498 cites W2094373312 @default.
• W2021000498 cites W2095777706 @default.
• W2021000498 cites W2102795669 @default.
• W2021000498 cites W2107804537 @default.
• W2021000498 cites W2111187586 @default.
• W2021000498 cites W2114129553 @default.
• W2021000498 cites W2124538980 @default.
• W2021000498 cites W2129932730 @default.
• W2021000498 cites W2130723719 @default.
• W2021000498 cites W2133548029 @default.
• W2021000498 cites W2135309154 @default.
• W2021000498 cites W2136750984 @default.
• W2021000498 cites W2140668393 @default.
• W2021000498 cites W2143302321 @default.
• W2021000498 cites W2144795344 @default.
• W2021000498 cites W2149631100 @default.
• W2021000498 cites W2159879659 @default.
• W2021000498 cites W2164307232 @default.
• W2021000498 cites W2166977775 @default.
• W2021000498 cites W2167937350 @default.
• W2021000498 cites W2168079270 @default.
• W2021000498 doi "https://doi.org/10.1074/jbc.m112.393751" @default.
• W2021000498 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3567657" @default.
• W2021000498 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23264626" @default.
• W2021000498 hasPublicationYear "2013" @default.
• W2021000498 type Work @default.
• W2021000498 sameAs 2021000498 @default.
• W2021000498 citedByCount "156" @default.
• W2021000498 countsByYear W20210004982013 @default.
• W2021000498 countsByYear W20210004982014 @default.
• W2021000498 countsByYear W20210004982015 @default.
• W2021000498 countsByYear W20210004982016 @default.
• W2021000498 countsByYear W20210004982017 @default.
• W2021000498 countsByYear W20210004982018 @default.
• W2021000498 countsByYear W20210004982019 @default.
• W2021000498 countsByYear W20210004982020 @default.

• next